New directions in the preoperative management of adenocarcinoma of the rectum
Division of Surgery, University of Texas Southwestern Medical Center, Dallas VA Medical Center, 4500 S. Lancaster Road, Dallas, TX 75225.Critical reviews in oncogenesis 11/2012; 17(4):393-6. DOI: 10.1615/CritRevOncog.v17.i4.80
Pathological complete response is observed in nearly 20% of patients with rectal cancer receiving preoperative chemoradiation. Patients who achieve a pathological complete response have better outcomes compared to patients experiencing no response or partial response. Current strategies have not demonstrated a substantial improvement in augmenting the ratio of responders to partial and nonresponders. The following discussion addresses possible strategies of investigation to increase patients achieving a complete obliteration of rectal tumors following neoadjuvant chemoradio therapies.
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.